phase readout
saveNCT05835986: A First-in-Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7507062 in Participants With Systemic Lupus Erythematosus
ACTIVE_NOT_RECRUITINGupdated 5d ago
community read0 votes
Sponsor: Hoffmann-La Roche. Phase: PHASE1. Conditions: Systemic Lupus Erythematosus
view source ↗
comments(0)
5-min edit window · permanent after that